|
|
|
Insider
Information: |
Schonharting Florian |
Relationship: |
10% Owner |
City: |
San Francisco |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
12,488,643 |
|
Indirect Shares
|
21,650,325 |
|
|
Direct
Value |
$4,526,233 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
34,138,968 |
|
|
Total
Value |
$4,526,233 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Osteologix, Inc. |
OLGXF |
10% Owner |
2010-06-11 |
20,000 |
2010-06-11 |
21,650,325 |
Premium* |
|
Novelion Therapeutics Inc |
NVLN |
10% Owner |
2014-07-11 |
6,447,626 |
|
0 |
Premium* |
|
Astex Pharmaceuticals Inc |
ASTX |
10% Owner |
2010-04-26 |
6,021,017 |
2009-08-17 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
52 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
NVLN |
Novelion Therapeutics Inc |
10% Owner |
|
2009-01-30 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
6,513,579 |
|
- |
|
NVLN |
Novelion Therapeutics Inc |
10% Owner |
|
2009-04-09 |
4 |
B |
$1.89 |
$948 |
D/D |
500 |
9,520,365 |
2.37 |
- |
|
ASTX |
Astex Pharmaceuticals Inc |
10% Owner |
|
2010-04-22 |
4 |
S |
$3.38 |
$9,466 |
D/D |
(2,800) |
6,402,416 |
0 |
- |
|
ASTX |
Astex Pharmaceuticals Inc |
10% Owner |
|
2009-08-26 |
4 |
B |
$2.81 |
$11,521 |
D/D |
4,100 |
6,224,627 |
2.37 |
- |
|
OLGXF |
Osteologix, Inc. |
Director |
|
2007-08-17 |
4 |
B |
$1.05 |
$5,250 |
D/D |
5,000 |
15,000 |
3.84 |
- |
|
OLGXF |
Osteologix, Inc. |
Director |
|
2007-08-23 |
4 |
B |
$1.14 |
$5,700 |
D/D |
5,000 |
20,000 |
3.84 |
- |
|
NVLN |
Novelion Therapeutics Inc |
10% Owner |
|
2009-03-20 |
4 |
B |
$1.65 |
$8,773 |
D/D |
5,200 |
7,458,706 |
2.37 |
- |
|
NVLN |
Novelion Therapeutics Inc |
10% Owner |
|
2009-03-19 |
4 |
B |
$1.70 |
$10,188 |
D/D |
5,993 |
7,453,506 |
2.37 |
- |
|
ASTX |
Astex Pharmaceuticals Inc |
10% Owner |
|
2009-09-04 |
4 |
B |
$2.87 |
$21,308 |
D/D |
7,400 |
6,501,529 |
2.37 |
- |
|
OLGXF |
Osteologix, Inc. |
Director |
|
2007-06-12 |
4 |
B |
$1.15 |
$11,500 |
D/D |
10,000 |
10,000 |
3.92 |
- |
|
ASTX |
Astex Pharmaceuticals Inc |
10% Owner |
|
2009-08-27 |
4 |
B |
$2.81 |
$30,743 |
D/D |
10,950 |
6,235,577 |
2.37 |
- |
|
NVLN |
Novelion Therapeutics Inc |
10% Owner |
|
2009-02-11 |
4 |
S |
$2.32 |
$52,188 |
D/D |
(22,495) |
6,912,505 |
0 |
- |
|
ASTX |
Astex Pharmaceuticals Inc |
10% Owner |
|
2009-09-14 |
4 |
B |
$2.85 |
$68,329 |
D/D |
23,700 |
6,525,229 |
2.45 |
- |
|
NVLN |
Novelion Therapeutics Inc |
10% Owner |
|
2009-02-11 |
4/A |
B |
$2.32 |
$64,647 |
D/D |
27,835 |
6,917,845 |
2.45 |
- |
|
ASTX |
Astex Pharmaceuticals Inc |
10% Owner |
|
2009-09-15 |
4 |
B |
$2.88 |
$105,052 |
D/D |
36,355 |
6,561,584 |
2.45 |
- |
|
NVLN |
Novelion Therapeutics Inc |
10% Owner |
|
2010-03-16 |
4 |
B |
$4.97 |
$203,977 |
D/D |
40,896 |
7,727,613 |
2.45 |
- |
|
ASTX |
Astex Pharmaceuticals Inc |
10% Owner |
|
2009-08-17 |
4 |
B |
$2.48 |
$118,141 |
D/D |
46,440 |
6,085,000 |
2.45 |
- |
|
ASTX |
Astex Pharmaceuticals Inc |
10% Owner |
|
2009-10-23 |
4 |
B |
$2.39 |
$119,984 |
D/D |
50,000 |
6,689,722 |
2.45 |
- |
|
NVLN |
Novelion Therapeutics Inc |
10% Owner |
|
2012-05-16 |
4 |
B |
$6.67 |
$333,340 |
D/D |
50,000 |
7,447,626 |
2.45 |
- |
|
ASTX |
Astex Pharmaceuticals Inc |
10% Owner |
|
2009-08-18 |
4 |
B |
$2.59 |
$145,798 |
D/D |
55,582 |
6,140,582 |
2.45 |
- |
|
ASTX |
Astex Pharmaceuticals Inc |
10% Owner |
|
2009-08-25 |
4 |
B |
$2.76 |
$173,392 |
D/D |
62,242 |
6,220,527 |
2.45 |
- |
|
NVLN |
Novelion Therapeutics Inc |
10% Owner |
|
2010-03-15 |
4 |
B |
$4.92 |
$334,008 |
D/D |
67,421 |
7,686,717 |
2.45 |
- |
|
NVLN |
Novelion Therapeutics Inc |
10% Owner |
|
2009-04-06 |
4 |
B |
$1.81 |
$141,299 |
D/D |
77,741 |
9,183,572 |
2.45 |
- |
|
ASTX |
Astex Pharmaceuticals Inc |
10% Owner |
|
2009-09-16 |
4 |
B |
$2.92 |
$232,390 |
D/D |
78,138 |
6,639,722 |
2.45 |
- |
|
NVLN |
Novelion Therapeutics Inc |
10% Owner |
|
2010-03-10 |
4 |
B |
$4.68 |
$386,877 |
D/D |
80,286 |
7,336,850 |
2.45 |
- |
|
52 Records found
|
|
Page 1 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|